Topological Structural Brain Connectivity Alterations in Aspartylglucosaminuria: A Case-Control Study

References

1. 1.↵
   1. Saarela J,
   2. von SC,
   3. Peltonen L, et al

   . A novel aspartylglucosaminuria mutation affects translocation of aspartylglucosaminidase. Hum Mutat 2004;24:350–51 doi:10.1002/humu.9276 pmid:15365992

   CrossRefPubMed
2. 2.↵
   1. Arvio M,
   2. Mononen I

   . Aspartylglycosaminuria: a review. Orphanet J Rare Dis 2016;11:162 doi:10.1186/s13023-016-0544-6 pmid:27906067

   CrossRefPubMed
3. 3.↵
   1. Syvänen AC,
   2. Ikonen E,
   3. Manninen T, et al

   . Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland. Genomics 1992;12:590–95 doi:10.1016/0888-7543(92)90452-X pmid:1559710

   CrossRefPubMed
4. 4.↵
   1. Goodspeed K,
   2. Feng C,
   3. Laine M, et al

   . Aspartylglucosaminuria: clinical presentation and potential therapies. J Child Neurol 2021;36:403–14 doi:10.1177/0883073820980904 pmid:33439067

   CrossRefPubMed
5. 5.↵
   1. Arvio M,
   2. Arvio P,
   3. Hurmerinta K, et al

   . Reduction in head size in patients with aspartylglucosaminuria. Acta Neurol Scand 2005;112:335–37 doi:10.1111/j.1600-0404.2005.00492.x pmid:16218917

   CrossRefPubMed
6. 6.↵
   1. Arvio P,
   2. Arvio M

   . Progressive nature of aspartylglucosaminuria. Acta Paediatr 2007;91:255–57 doi:10.1111/j.1651-2227.2002.tb01707.x pmid:12022293

   CrossRefPubMed
7. 7.↵
   1. Dunder U,
   2. Valtonen P,
   3. Kelo E, et al

   . Early initiation of enzyme replacement therapy improves metabolic correction in the brain tissue of aspartylglycosaminuria mice. J Inherit Metab Dis 2010;33:611–17 doi:10.1007/s10545-010-9158-7 pmid:20607610

   CrossRefPubMed
8. 8.↵
   1. Kelo E,
   2. Dunder U,
   3. Mononen I

   . Massive accumulation of Man2GlcNAc2-Asn in nonneuronal tissues of glycosylasparaginase-deficient mice and its removal by enzyme replacement therapy. Glycobiology 2005;15:79–85 doi:10.1093/glycob/cwh145 pmid:15342551

   CrossRefPubMed
9. 9.↵
   1. Peltola M,
   2. Kyttälä A,
   3. Heinonen O, et al

   . Adenovirus-mediated gene transfer results in decreased lysosomal storage in brain and total correction in liver of aspartylglucosaminuria (AGU) mouse. Gene Ther 1998;5:1314–21 doi:10.1038/sj.gt.3300740 pmid:9930336

   CrossRefPubMed
10. 10.↵
    1. Virta S,
    2. Rapola J,
    3. Jalanko A, et al

    . Use of nonviral promoters in adenovirus-mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse. J Gene Med 2006;8:699–706 doi:10.1002/jgm.892 pmid:16518877

    CrossRefPubMed
11. 11.↵
    1. Banning A,
    2. Gülec C,
    3. Rouvinen J, et al

    . Identification of small molecule compounds for pharmacological chaperone therapy of aspartylglucosaminuria. Sci Rep 2016;6:37583 doi:10.1038/srep37583 pmid:27876883

    CrossRefPubMed
12. 12.↵
    1. Autti T,
    2. Joensuu R,
    3. Åberg L

    . Decreased T2 signal in the thalami may be a sign of lysosomal storage disease. Neuroradiology 2007;49:571–78 doi:10.1007/s00234-007-0220-6 pmid:17334752

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Autti T,
    2. Lönnqvist T,
    3. Joensuu R

    . Bilateral pulvinar signal intensity decrease on T2-weighted images in patients with aspartylglucosaminuria. Acta Radiol 2008;49:687–92 doi:10.1080/02841850802065000 pmid:18568562

    CrossRefPubMed
14. 14.↵
    1. Tokola A,
    2. Åberg L,
    3. Autti T

    . Brain MRI findings in aspartylglucosaminuria. J Neuroradiol 2015;42:345–57 doi:10.1016/j.neurad.2015.03.003 pmid:26026191

    CrossRefPubMed
15. 15.↵
    1. Autti T,
    2. Raininko R,
    3. Haltia M, et al

    . Aspartylglucosaminuria: radiologic course of the disease with histopathologic correlation. J Child Neurol 1997;12:369–75 doi:10.1177/088307389701200606 pmid:9309520

    CrossRefPubMed
16. 16.↵
    1. Goodspeed K,
    2. Horton D,
    3. Lowden A, et al

    . A cross-sectional natural history study of aspartylglucosaminuria. JIMD Rep 2022;63:425–33 doi:10.1002/jmd2.12294 pmid:36101820

    CrossRefPubMed
17. 17.↵
    1. Tokola A,
    2. Brandstack N,
    3. Hakkarainen A, et al

    . White matter microstructure and subcortical gray matter structure volumes in aspartylglucosaminuria; a 5-year follow-up brain MRI study of an adolescent with aspartylglucosaminuria and his healthy twin brother. JIMD Rep 2017;35:105–15 doi:10.1007/8904_2016_36 pmid:28185224

    CrossRefPubMed
18. 18.↵
    1. Hagmann P,
    2. Cammoun L,
    3. Gigandet X, et al

    . Mapping the structural core of human cerebral cortex. PLoS Biol 2008;6:e159–93 doi:10.1371/journal.pbio.0060159 pmid:18597554

    CrossRefPubMed
19. 19.↵
    1. Bullmore E,
    2. Sporns O

    . Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 2009;10:186–98 doi:10.1038/nrn2575 pmid:19190637

    CrossRefPubMed
20. 20.↵
    1. Griffa A,
    2. Baumann PS,
    3. Thiran JP, et al

    . Structural connectomics in brain diseases. Neuroimage 2013;80:515–26 doi:10.1016/j.neuroimage.2013.04.056 pmid:23623973

    CrossRefPubMed
21. 21.↵
    1. Roine T,
    2. Jeurissen B,
    3. Perrone D, et al

    . Reproducibility and intercorrelation of graph theoretical measures in structural brain connectivity networks. Med Image Anal 2019;52:56–67 doi:10.1016/j.media.2018.10.009 pmid:30471463

    CrossRefPubMed
22. 22.↵
    1. Lei D,
    2. Li W,
    3. Tallman MJ, et al

    . Changes in the brain structural connectome after a prospective randomized clinical trial of lithium and quetiapine treatment in youth with bipolar disorder. Neuropsychopharmacology 2021;46:1315–23 doi:10.1038/s41386-021-00989-5 pmid:33753882

    CrossRefPubMed
23. 23.↵
    1. Hu M,
    2. Zong X,
    3. Zheng J, et al

    . Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study. Psychol Med 2016;46:2549–60 doi:10.1017/S0033291716001380 pmid:27338296

    CrossRefPubMed
24. 24.↵
    1. Roine T,
    2. Roine U,
    3. Tokola A, et al

    . Topological alterations of the structural brain connectivity network in children with juvenile neuronal ceroid lipofuscinosis. AJNR Am J Neuroradiol 2019;40:2146–53 doi:10.3174/ajnr.A6306 pmid:31727742

    CrossRefPubMed
25. 25.↵
    1. Leemans A,
    2. Jones DK

    . The B-matrix must be rotated when correcting for subject motion in DTI data. Magn Reson Med 2009;61:1336–49 doi:10.1002/mrm.21890 pmid:19319973

    CrossRefPubMed
26. 26.↵
    1. Leemans A,
    2. Jeurissen B,
    3. Sijbers J, et al

    . ExploreDTI: a graphical toolbox for processing, analyzing, and visualizing diffusion MR data. January 2009. In: Proceedings of the 17th Annual Meeting of the International Society for Magnetic Resonance in Medicine, 2009;3537
27. 27.↵
    1. Irfanoglu MO,
    2. Walker L,
    3. Sarlls J, et al

    . Effects of image distortions originating from susceptibility variations and concomitant fields on diffusion MRI tractography results. Neuroimage 2012;61:275–88 doi:10.1016/j.neuroimage.2012.02.054 pmid:22401760

    CrossRefPubMed
28. 28.↵
    1. Jeurissen B,
    2. Leemans A,
    3. Jones DK, et al

    . Probabilistic fiber tracking using the residual bootstrap with constrained spherical deconvolution. Hum Brain Mapp 2011;32:461–79 doi:10.1002/hbm.21032 pmid:21319270

    CrossRefPubMed
29. 29.↵
    1. Tournier JD,
    2. Calamante F,
    3. Connelly A

    . Robust determination of the fibre orientation distribution in diffusion MRI: non-negativity constrained super-resolved spherical deconvolution. Neuroimage 2007;35:1459–72 doi:10.1016/j.neuroimage.2007.02.016 pmid:17379540

    CrossRefPubMed
30. 30.↵
    1. Destrieux C,
    2. Fischl B,
    3. Dale A, et al

    . Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature. Neuroimage 2010;53:1–15 doi:10.1016/j.neuroimage.2010.06.010 pmid:20547229

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Fischl B

    . FreeSurfer. Neuroimage 2012;62:774–81 doi:10.1016/j.neuroimage.2012.01.021 pmid:22248573

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Rubinov M,
    2. Sporns O

    . Complex network measures of brain connectivity: uses and interpretations. Neuroimage 2010;52:1059–69 doi:10.1016/j.neuroimage.2009.10.003 pmid:19819337

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Mann HB,
    2. Whitney DR

    . On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 1947;18:50–60 doi:10.1214/aoms/1177730491

    CrossRef
34. 34.↵
    1. Xia M,
    2. Wang J,
    3. He Y

    . BrainNet Viewer: a network visualization tool for human brain connectomics. PLoS One 2013;8:e68910 doi:10.1371/journal.pone.0068910 pmid:23861951

    CrossRefPubMed
35. 35.↵
    1. Tournier JD,
    2. Smith R,
    3. Raffelt D, et al

    . MRtrix3: a fast, flexible and open software framework for medical image processing and visualisation. Neuroimage 2019;202:116137 doi:10.1016/j.neuroimage.2019.116137 pmid:31473352

    CrossRefPubMed
36. 36.↵
    1. Waskom M

    . Seaborn: statistical data visualization. J Open Source Softw. 2021;6:3021 doi:10.21105/joss.03021

    CrossRef
37. 37.↵
    1. Hunter JD

    . Matplotlib: a 2D graphics environment. Comput Sci Eng 2007;9:90–95 doi:10.1109/MCSE.2007.55

    CrossRef
38. 38.↵
    1. Latora V,
    2. Marchiori M

    . Efficient behavior of small-world networks. Phys Rev Lett 2001;87:198701 doi:10.1103/PhysRevLett.87.198701 pmid:11690461

    CrossRefPubMed
39. 39.↵
    1. Watts DJ,
    2. Strogatz SH

    . Collective dynamics of “small-world” networks. Nature 1998;393:440–42 doi:10.1038/30918 pmid:9623998

    CrossRefPubMed
40. 40.↵
    1. Saramäki J,
    2. Kivelä M,
    3. Onnela JP, et al

    . Generalizations of the clustering coefficient to weighted complex networks. Phys Rev E Stat Nonlin Soft Matter Phys.2007;75(2 Pt 2):027105 doi:10.1103/PhysRevE.75.027105 pmid:17358454

    CrossRefPubMed
41. 41.↵
    1. Arstila A,
    2. Palo J,
    3. Haltia M, et al

    . Aspartylglucosaminuria I: fine structural studies on liver, kidney and brain. Acta Neuropathol 1972;20:207–16 doi:10.1007/BF00686902 pmid:5044001

    CrossRefPubMed
42. 42.↵
    1. Haltia M,
    2. Palo J,
    3. Autio S

    . Aspartylglycosaminuria: a generalized storage disease. Acta Neuropathol 1975;31:243–55 doi:10.1007/BF00684563 pmid:1138532

    CrossRefPubMed
43. 43.↵
    1. Tokola A,
    2. Laine M,
    3. Tikkanen R, et al

    . Susceptibility-weighted imaging findings in aspartylglucosaminuria. AJNR Am J Neuroradiol 2019;40:1850–54 doi:10.3174/ajnr.A6288 pmid:31649158

    CrossRefPubMed
44. 44.↵
    1. Sairanen V,
    2. Tokola A,
    3. Tikkanen R, et al

    . Statistical permutation test reveals progressive and region-specific iron accumulation in the thalami of children with aspartylglucosaminuria. Brain Sci 2020;10:677 doi:10.3390/brainsci10100677 pmid:32992453

    CrossRefPubMed
45. 45.↵
    1. Dimov A,
    2. Patel W,
    3. Yao Y, et al

    . Iron concentration linked to structural connectivity in the subthalamic nucleus: implications for deep brain stimulation. J Neurosurg 2019 Jan 18. [Epub head of print] doi:10.3171/2018.8.JNS18531 pmid:30660115

    CrossRefPubMed
46. 46.↵
    1. Zachariou V,
    2. Bauer CE,
    3. Seago ER, et al

    . Cortical iron disrupts functional connectivity networks supporting working memory performance in older adults. Neuroimage 2020;223:117309 doi:10.1016/j.neuroimage.2020.117309 pmid:32861788

    CrossRefPubMed
47. 47.↵
    1. Acheson DJ,
    2. Hagoort P

    . Stimulating the brain’s language network: syntactic ambiguity resolution after TMS to the inferior frontal gyrus and middle temporal gyrus. J Cogn Neurosci 2013;25:1664–77 doi:10.1162/jocn_a_00430

    CrossRef
48. 48.↵
    1. Binder JR,
    2. Frost JA,
    3. Hammeke TA, et al

    . Function of the left planum temporale in auditory and linguistic processing. Brain 1996;119:1239–47 doi:10.1093/brain/119.4.1239 pmid:8813286

    CrossRefPubMed
49. 49.↵
    1. Keenan JP,
    2. Thangaraj V,
    3. Halpern AR, et al

    . Absolute pitch and planum temporale. Neuroimage 2001;14:1402–08 doi:10.1006/nimg.2001.0925 pmid:11707095

    CrossRefPubMed
50. 50.↵
    1. Dorsaint-Pierre R,
    2. Penhune VB,
    3. Watkins KE, et al

    . Asymmetries of the planum temporale and Heschl’s gyrus: relationship to language lateralization. Brain 2006;129:1164–76 doi:10.1093/brain/awl055 pmid:16537567

    CrossRefPubMedWeb of Science
51. 51.↵
    1. Larsen JP,
    2. Høien T,
    3. Lundberg I, et al

    . MRI evaluation of the size and symmetry of the planum temporale in adolescents with developmental dyslexia. Brain Lang 1990;39:289–301 doi:10.1016/0093-934X(90)90015-9 pmid:2224496

    CrossRefPubMed
52. 52.↵
    1. Foundas AL,
    2. Bollich AM,
    3. Feldman J, et al

    . Aberrant auditory processing and atypical planum temporale in developmental stuttering. Neurology 2004;63:1640–46 doi:10.1212/01.WNL.0000142993.33158.2A pmid:15534249

    CrossRefPubMed
53. 53.↵
    1. Roine U,
    2. Roine T,
    3. Hakkarainen A, et al

    . Global and widespread local white matter abnormalities in juvenile neuronal ceroid lipofuscinosis. AJNR Am J Neuroradiol 2018;39:1349–54 doi:10.3174/ajnr.A5687 pmid:29853519

    CrossRefPubMed
54. 54.↵
    1. Tournier JD,
    2. Calamante F,
    3. Connelly A

    . Determination of the appropriate b value and number of gradient directions for high-angular-resolution diffusion-weighted imaging. NMR Biomed 2013;26:1775–86 doi:10.1002/nbm.3017 pmid:24038308

    CrossRefPubMed
55. 55.↵
    1. Raffelt D,
    2. Tournier JD,
    3. Rose S, et al

    . Apparent fibre density: a novel measure for the analysis of diffusion-weighted magnetic resonance images. Neuroimage 2012;59:3976–94 doi:10.1016/j.neuroimage.2011.10.045 pmid:22036682

    CrossRefPubMed